Clinical Research in Southampton
Southampton Children's Hospital

A A A Text only | Accessibility | Privacy and cookies

Home
About the Trust
Our services
Patients and visitors
Our hospitals
Education
Research
Working here
Contact us

Browse site A to Z

A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

Search results

Go To Simple Search

Search Type: Criteria:

You could also try: lady (30), female (148)

Curves in the spine - patient information

Description: We've written this booklet as a guide to scoliosis and hyperkyphosis, two kinds of curve in the spine.
Url: /Media/UHS-website-2019/Patientinformation/Childhealth/Curves-in-the-spine-1557-PIL.pdf

Professor Graham Burdge

Description: Professor Graham Burdge Graham Burdge passed away at home on the 1st February 2024 as the result of a brain tumour
Url: /Media/Southampton-Clinical-Research/Downloads/Professor-Graham-Burdge.pdf

Your baby's movements - patient information

Description: This factsheet contains information about your baby's movements during pregnancy.
Url: /Media/UHS-website-2019/Patientinformation/Pregnancyandbirth/Your-babys-movements-3102-PIL.pdf

Your birth story: Having a caesarean birth under general anaesthetic - patient information

Description: This booklet contains birth details for people who have had a caesarean birth while under general anaesthetic.
Url: /Media/UHS-website-2019/Patientinformation/Pregnancyandbirth/Your-birth-story-Having-a-caesarean-birth-under-general-anaesthetic-3285-PIL.pdf

Carboplatin (AUC6) Retreat

Description: Chemotherapy Protocol GYNAECOLOGICAL CANCER CARBOPLATIN Retreat Regimen (AUC6) • Ovary – Carboplatin (AUC6) Retreat Indication • Second line or subsequent treatment of platinum sensitive
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Ovarian-cancer/CarboplatinAUC6Retreat.pdf

Carboplatin (AUC5)

Description: Chemotherapy Protocol GYNAECOLOGICAL CANCER CARBOPLATIN (AUC5) Regimen • Ovary – Carboplatin (AUC 5) Indication • Adjuvant treatment in patients with moderate to high risk
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Ovarian-cancer/CarboplatinAUC5.pdf

Finance and Performance Reports 2020-21 Month 4 July 2020

Description: 2020/21 Finance Report - Month 4 Report to: Board of Directors and Finance & Investment Committee August 2020 Title: Finance Report for
Url: /Media/UHS-website-2019/Docs/About-the-Trust/Trust-governance-and-corporate-docs/2020/finance-and-performance-reports-2020-21-month-4-july-2020-1.pdf

Carboplatin (AUC6)

Description: Chemotherapy Protocol GYNAECOLOGICAL CANCER Regimen CARBOPLATIN (AUC6) 6 CYCLES  Ovary – Carboplatin (AUC6) 6 Cycles Indication  Adjuvant treatment in patients with moderate
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Ovarian-cancer/CarboplatinAUC6.pdf

InP RIVAC (66) cytarabine etoposide ifosfamide rituximab

Description: Chemotherapy Protocol LYMPHOMA CYTARABINE-ETOPOSIDE-IFOSFAMIDE-RITUXIMAB (RIVAC) 66 years and above Inpatient Regimen There are multiple versions of this protocol
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lymphoma/InP-RIVAC-66-cytarabine-etoposide-ifosfamide-rituximab.pdf

InP RIVAC (65) cytarabine etoposide ifosfamide rituximab

Description: Chemotherapy Protocol LYMPHOMA CYTARABINE-ETOPOSIDE-IFOSFAMIDE-RITUXIMAB (RIVAC) 65 years and below Inpatient Regimen There are multiple versions of this protocol
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lymphoma/InP-RIVAC-65-cytarabine-etoposide-ifosfamide-rituximab.pdf

111 to 120 of 349

Previous … 10 11 12 13 14 … Next